The following represents disclosure information provided by authors of this abstract. The ASCO Scientific Program Committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered self-held and compensated unless otherwise noted. Employment/Leadership relationships are considered compensated employment unless otherwise noted. L = Leadership, U = Uncompensated, I = Immediate Family Member, B = Both Myself and Immediate Family Member, Inst = My Institution
Circulating DNA as a strong multimarker prognostic tool in metastatic colorectal cancer patients.
Safia El Messaoudi
No relevant relationships to disclose
Florent Mouliere
No relevant relationships to disclose
Caroline Mollevi
No relevant relationships to disclose
Brigitte Gillet
No relevant relationships to disclose
Michelle Nouaille
No relevant relationships to disclose
Virginie Loriot
No relevant relationships to disclose
Denis Pezet
Honoraria - Sanofi
Muriel Mathonnet
Consultant or Advisory Role - Amgen; Sanofi
Marc Ychou
Consultant or Advisory Role - Amgen; Bayer; Roche; Sanofi
Alain Roger Thierry
No relevant relationships to disclose